Lunai Bioworks (LNAI) Operating Expenses (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Operating Expenses of $1.4 million for Q1 2026, down 65.21% year-over-year from $4.2 million in Q1 2025, and down 20.58% quarter-over-quarter from $1.8 million in Q4 2025.
Lunai Bioworks (LNAI) Operating Expenses (2011 - 2026) Analysis & Trends
Lunai Bioworks' Operating Expenses history runs 16 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 65.21% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $133.5 million (up 68.66% YoY), while the FY2025 annual figure was $189.0 million, up 131.46% from the prior year.
- Operating Expenses for Q1 2026 stood at $1.4 million, down from $1.8 million in the prior quarter.
- The five-year high for Operating Expenses was $126.9 million in Q2 2025, with the low at $1.4 million in Q1 2026.
- The 5-year median for Operating Expenses is $4.5 million (2024), against an average of $24.6 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses soared 1164.47% in 2024, then plunged 93.8% in 2025.
- Lunai Bioworks' Operating Expenses stood at $4.4 million in 2022, then retreated by 2.24% to $4.3 million in 2023, then grew by 6.47% to $4.5 million in 2024, then plunged by 59.89% to $1.8 million in 2025, then slipped by 20.58% to $1.4 million in 2026.
- Business Quant data shows LNAI's Operating Expenses at $1.4 million in Q1 2026, $1.8 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 126.92 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 53.34 Mn |
| Jun 30, 2024 | 17.10 Mn |
| Mar 31, 2024 | 51.38 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Sep 30, 2023 | 8.88 Mn |
| Jun 30, 2023 | 22.93 Mn |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 4.37 Mn |
| Sep 30, 2022 | 7.19 Mn |
| Jun 30, 2022 | 98.21 Mn |
| Mar 31, 2022 | 4.03 Mn |
| Dec 31, 2021 | 6.33 Mn |
| Sep 30, 2021 | 7.50 Mn |
| Jun 30, 2021 | 14.18 Mn |